Current opinion on the therapy of perianal fistulas in patients with Crohn's disease
Martin Bortlík Orcid.org 1,2,3
+ Affiliation
Summary
Perianal fistulas affect more than one third of patients suffering from Crohn's disease. They represent severe phenotype of the disease and substantially decrease the quality of life in affected patients. Therapy requires a complex approach with combination and appropriate coordination of medical treatment and surgical techniques. Using the current medicines, especially biologies, as well as propper surgery, we can achieve the long-term healing in more than 2/3 of patients with perianal Crohn's disease.
Keywords
Crohn’s disease, adalimumab, infliximabTo read this article in full, please register for free on this website.
Benefits for subscribers
Benefits for logged users